Prenetics reported an initial statement of beneficial ownership by director David Vanderveen. Vanderveen reported direct beneficial ownership of 38,305 Class A ordinary shares. He also reported indirect beneficial ownership of 1,648 Class A ordinary shares held by his spouse. Vanderveen reported 8,681 restricted stock units, each convertible into one Class A ordinary share at an exercise price of USD 0.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prenetics Global Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-019142), on March 18, 2026, and is solely responsible for the information contained therein.
Comments